Millipore Sigma Vibrant Logo

MMA130 Millicell® µ-Angiogenesis Activation Assay Kit

The Millicell μ-Angiogenesis activation assay kits provide a powerful, quantitative platform for real-time monitoring of changes in tubule formation with unprecedented optical resolution.

FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.
Key Applications: Activity Assay, Cell Culture
MMA130
1 Kit  
Prix en cours de récupération
Le prix n'a pas pu être récupéré
La quantité minimale doit être un multiple de
Maximum Quantity is
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
—
Demander le prix
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

       

      Contacter le Service Clients

      Aperçu

      Replacement Information

      Tableau de caractéristiques principal

      Key ApplicationsDetection Methods
      ACT, CULTFluorescent
      Description
      Catalogue NumberMMA130
      Trade Name
      • Millicell
      DescriptionMillicell® µ-Angiogenesis Activation Assay Kit
      OverviewOverview

      Studying how compounds affect angiogenesis, either to promote or inhibit new capillary tube formation can lead to therapies affecting wound healing, tissue regeneration, cardiovascular disease, stroke, tumor progression, and more. The Millicell μ-Angiogenesis activation and inhibition kits provide a powerful, quantitative platform for real-time monitoring of changes in tubule formation with unprecedented optical resolution.
      Benefits

      • Continuous, live monitoring of cells as tubules form
      • Even, flat slide surface prevents any liquid meniscus from forming, eliminating out-of-focus areas
      • Full well visualization at low magnification
      • Optimized assay conditions in a miniaturized format
      • Compatible with multi-channel pipettes and fixation reagents
      • Less reagents and cells needed, reducing costs and waste by up to 80%
      • All-in-one slide used to grow, assay, and stain cells



      Studying how compounds affect angiogenesis, either to promote or inhibit new capillary tube formation, can lead to therapies affecting wound healing, tissue regeneration, cardiovascular disease, stroke, tumor progression, and more. The Millicell® μ-Angiogenesis activation and inhibition assay kits provide a powerful, quantitative platform for real-time monitoring of changes in tubule formation with unprecedented optical resolution.

      Applications

      • Angiogenesis Assays


      For more information on Cell Culture & Systems visit: www.emdmillipore.com/cellculture
      Materials Required but Not Delivered1. Inverted Light Microscope
      2. Fluorescent microscope (if Calcein AM is used)
      3. Precision pipettes
      4. Accutase™ Cell Dissociation Solution (Catalog. No. SCR005)
      5. Human umbilical vein endothelial cells (HUVEC) (Catalog No. SCCE001) or any other experimental cell lines capable of tube formation.
      6. EndoGRO™ LS Complete Medium (Cat. No. SCME001) or other endothelial cell basal medium.
      7. Phosphate-Buffered Saline (1X PBS) (Catalog No. BSS-1005-B)
      8. Sterile distilled water (Cat. No. TMS-006-C or TMS-006-B)
      9. Low speed centrifuge
      10. Sterile eppendorf tubes
      11. Precision pipette tips. We recommend 0.1–10 mL TipOne filter tips (USA Scientific Catalog No. 1121-3810) or Rainin’s 20 µL Precision Pipette Tips (Rainin Catalog No. RT-L10S)
      12. 37ºC Incubator with 5% CO2
      13. Hemacytometer
      14. Trypan Blue
      15. DMSO
      Background InformationAngiogenesis, the formation of new blood vessels from a pre-existing vascular network, occurs normally in development and is critical for a majority of the vessel formation that occurs during embryogenesis, tissue generation, and wound healing. However, abnormal blood vessel growth, either excessive or insufficient, can be the underlying cause of many deadly and debilitating diseases including cancer, cardiovascular disease, stroke, and diabetic and age-related blindness. Identification of specific compounds that promote or inhibit angiogenesis may provide promising treatments for these diseases.

      Tubular formation is a multi-step process involving cell adhesion, migration, differentiation, and growth. Millipore’s Millicell® µ-Angiogenesis Inhibition Assay provides an efficient system for the rapid and accurate identification of factors that inhibit tube formation of endothelial cells. The µ-Angiogenesis slide, with enhanced optical capabilities in a microscale format, allows for real time and continuous monitoring of tube formation in a simplifed and reproducible manner.
      References
      Product Information
      Components
      • 1. Millicell® µ-Angiogenesis Slides: (Part No. CS203030) Five tissue culture treated slides. Each slide contains 15 wells.
      • 2. Fibrinogen Solution: (Part No. CS203035) One 1.5 mL vial.
      • 3. Thrombin Solution: (Part No. CS203036) One 0.75 mL vial.
      • 4. ITS Media Supplement, 100X: (Part No. CS203037) One 0.5 mL vial.
      • 5. PMA (Phorbol 12-Myristate 13-Acetate): (Part No. CS203029): One 1 mg vial.
      • 6. Calcein-AM: (Part No. CS202541) One 50 µg vial.
      Detection methodFluorescent
      Applications
      ApplicationThe Millicell μ-Angiogenesis activation assay kits provide a powerful, quantitative platform for real-time monitoring of changes in tubule formation with unprecedented optical resolution.
      Key Applications
      • Activity Assay
      • Cell Culture
      Biological Information
      Species Reactivity
      • Vertebrates
      • Rat
      • Human
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage Conditions1. Millicell® µ-Angiogenesis Slides (Part No. CS203030) should be stored at room temperature until ready to use.
      2. Fibrinogen Solution (Part No. CS203035) should be stored at -20ºC and used within six months from the date of receipt. For short-term storage, store at room temperature for up to 2 weeks. Do not store at 4ºC, as Fibrinogen Solutions tend to form aggregates when stored at 4ºC. For long-term storage, aliquot into sterile tubes in a sterile laminar flow hood, freeze on dry ice, and store at -20ºC.
      3. Thrombin Solution (Part No. CS203036) should be stored at -20ºC and used within six months from the date of receipt. Unused Thrombin Solution can be stored at 4ºC for up to 1 month. For longer term storage, Thrombin Solution may be stored in aliquots at -20ºC.
      4. ITS Media Supplement, 100X (Part No. CS203037) should be stored at -20ºC. Unused portions may also be stored at 4ºC for up to 1 year. Avoid freeze thaw cycles.
      5. PMA (Phorbol-12-Myristate-13-Acetate) (Part No. CS203029) is provided as a 1 mg lyophilized powder. To prepare a 1 mg/mL stock, add 1 mL sterile DMSO (not provided). Vortex vigorously. Centrifuge briefly to collect the solution. Unused PMA Solution may be stored at -20ºC in the dark for at least six months. WARNING: Highly irritating to skin and mucous membranes. TUMOR PROMOTER. Read the Material Safety Data Sheet (MSDS) prior to rehydration and use. Gloves and mask should be worn when using this compound.
      6. Calcein AM (Part No. CS202541) is provided as a 50 µg lyophilized powder. To prepare 1 mM Calcein AM Stock Solution, briefly centrifuge before opening the tube and then add 40 µL sterile DMSO (not provided). Vortex vigorously. Centrifuge briefly to collect the solution. Unused Calcein AM Solution may be stored in aliquots at –20ºC for up to 1 month.
      Packaging Information
      Material Size1 Kit
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      MMA130 04053252005282